Post-renovation BioPort ProductionFDA Lot-Release AuthorizationsThese memos show the authority for the manufacturer to release anthrax vaccine from the manufacturing plant. Each lot of every vaccine produced in the United States must be individually released in this way, after having been tested for sterility, purity, potency, and general safety. Lot-release tests are performed by the manufacturer and audited by FDA.